# Adalimumab

## Humira inj 40mg/0.4mL

| TAH Drug Code      | [IHUM5](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IHUM5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Indicated for the treatment of rheumatoid arthritis, juvenile idiopathic polyarthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis, hidradenitis suppurativa, adult and pediatric Crohn's disease, ulcerative colitis, intestinal Behcet's disease, non-infectious intermediate, posterior, and pan-uveitis in adults, and non-infectious anterior uveitis in children.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | SC, Adult Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis 40 mg every other week. If not taking concomitantly with methotrexate, increasing the dosing frequency to 40 mg weekly may derive additional benefit. Crohn's disease, ulcerative colitis 160 mg initially at day 1 (as four 40-mg in 1 day or as two 40-mg/day for 2 consecutive days), followed by 80 mg 2 weeks later (day 15). Another 2 weeks later (day 29) begin a maintenance dose of 40 mg every other week. Patients who experience decrease in their response may benefit from an increase in dose intensity to 40 mg every week. Plaque psoriasis Initially 80 mg, followed by 40 mg given every other week starting 1 week after the initial dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Known hypersensitivity to adalimumab or any of the excipients of Humira.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Common: Injection site disorder (5-20%), Injection site pain (Pediatric, 6-19%), Rash (12%), Headache (12%), Sinusitis (11%), Upper respiratory infection (17%) Serious: Atrial fibrillation (Less than 5%), Cardiac arrest (Less than 5%), Cardiac dysrhythmia (Less than 5%), Chest pain (Less than 5%), Congestive heart failure, Hypertensive encephalopathy (Less than 5%), Myocardial infarction (Less than 5%), Palpitations (Less than 5%), Pericardial effusion (Less than 5%), Pericarditis (Less than 5%), Syncope (Less than 5%), Erythema multiforme, Stevens-Johnson syndrome, Gastrointestinal hemorrhage (Less than 5%), Agranulocytosis (Less than 5%), Erythrocytosis (Less than 5%), Leukopenia (Infrequent), Pancytopenia (Rare), Thrombocytopenia (Infrequent), Thrombosis, Leg (Less than 5%), Hepatic failure, acute, Hepatic necrosis (Less than 5%), Reactivation of hepatitis B viral hepatitis, Hepatosplenic T-cell lymphoma, Herpes zoster, Hypersensitivity reaction (Pediatric, 5-6%), Malignant lymphoma, Bone necrosis (Less than 5%), Demyelinating disease of central nervous system (Rare), Peripheral demyelinating neuropathy (Rare), Subdural hematoma (Less than 5%), Bronchospasm (Less than 5%), Dyspnea (Less than 5%), Pleural effusion (Less than 5%), Tuberculosis, Infectious disease (Pediatric, 45-78%), Invasive fungal infection |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| More Info          | [UpToDate](https://www.uptodate.com/contents/adalimumab-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

